Would you consider dose or margin alterations when treating a multifocal squamous cell carcinoma of the lower esophagus/GEJ and stomach in the neoadjuvant setting?

Community
Company
News
Contact Us
Sign in

Topics: Radiation Oncology • Gastrointestinal Cancers • Gastric Cancer • Gastric/GEJ Cancer

How would you design the radiation volume and what considerations go into choosing a dose?

Related Questions

What are your top takeaways in GI Cancers from ASCO 2023?

Would you offer HAI (hepatic arterial infusion) or Y90 for colorectal liver metastases as a bridge to transplant?

For a patient with a lung tumor that is radiographically consistent with early-stage NSCLC but pathology with characteristics overlapping with upper GI origin, what additional diagnostic procedures would you consider before treating?

How would you alter your treatment volumes in a patient with distal esophageal cancer who has had prior gastric bypass surgery?

For a pedunculated rectal polyp found to be adenocarcinoma after endoscopic removal, with PNI as the only adverse feature, would you recommend additional treatment such as surgery or chemoradiation?

Would you offer RT for a low-grade esophageal GIST if the patient was not a surgical candidate?

Do you consider any "favorable" subset of patients with stage IV pancreatic cancer to be candidates for local pre-operative CRT and surgical resection?

In patients with perianal squamous cell carcinoma extending to the vulva, would you cover the entire vulva or would generous margins on the gross disease suffice?

In patients with active IBD and rectal cancer, do you take any precautions before starting TNT?

How would you treat a patient with a synchronous T1N2 non-small cell lung cancer and a T3N1 mid-rectal adenocarcinoma (MMR intact)?